High and Low-Frequency Stimulation Effect on Epileptiform Activity in Brain Slices.

Brain Slice Epileptiform activity High-frequency stimulation Low-frequency stimulation

Journal

Medical journal of the Islamic Republic of Iran
ISSN: 1016-1430
Titre abrégé: Med J Islam Repub Iran
Pays: Iran
ID NLM: 8910777

Informations de publication

Date de publication:
2023
Historique:
received: 04 10 2022
medline: 7 6 2023
pubmed: 7 6 2023
entrez: 7 6 2023
Statut: epublish

Résumé

Neurostimulation is one of the new therapeutic approaches in patients with drug-resistant epilepsy, and despite its high efficiency, its mechanism of action is still unclear. On the one hand, electrical stimulation in the human brain is immoral; on the other hand, the creation of the epilepsy model in laboratory animals affects the entire brain network. As a result, one of the ways to achieve the neurostimulation mechanism is to use epileptiform activity models In vitro. In vitro models, by accessing the local network from the whole brain, we can understand the mechanisms of action of neurostimulation. A literature search using scientific databases including PubMed, Google Scholar, and Scopus, using "Neurostimulation" and "epileptiform activity" combined with "high-frequency stimulation", " low-frequency stimulation ", and "brain slices" as keywords were conducted, related concepts to the topic gathered and are used in this paper. Electrical stimulation causes neuronal depolarization and the release of GABAA, which inhibits neuronal firing. Also, electrical stimulation inhibits the nervous tissue downstream of the stimulation site by preventing the passage of nervous activity from the upstream to the downstream of the axon. Neurostimulation techniques consisting of LFS and HFS have a potential role in treating epileptiform activity, with some studies having positive results. Further investigations with larger sample sizes and standardized outcome measures can be conducted to validate the results of previous studies.

Sections du résumé

Background UNASSIGNED
Neurostimulation is one of the new therapeutic approaches in patients with drug-resistant epilepsy, and despite its high efficiency, its mechanism of action is still unclear. On the one hand, electrical stimulation in the human brain is immoral; on the other hand, the creation of the epilepsy model in laboratory animals affects the entire brain network. As a result, one of the ways to achieve the neurostimulation mechanism is to use epileptiform activity models In vitro. In vitro models, by accessing the local network from the whole brain, we can understand the mechanisms of action of neurostimulation.
Methods UNASSIGNED
A literature search using scientific databases including PubMed, Google Scholar, and Scopus, using "Neurostimulation" and "epileptiform activity" combined with "high-frequency stimulation", " low-frequency stimulation ", and "brain slices" as keywords were conducted, related concepts to the topic gathered and are used in this paper.
Results UNASSIGNED
Electrical stimulation causes neuronal depolarization and the release of GABAA, which inhibits neuronal firing. Also, electrical stimulation inhibits the nervous tissue downstream of the stimulation site by preventing the passage of nervous activity from the upstream to the downstream of the axon.
Conclusion UNASSIGNED
Neurostimulation techniques consisting of LFS and HFS have a potential role in treating epileptiform activity, with some studies having positive results. Further investigations with larger sample sizes and standardized outcome measures can be conducted to validate the results of previous studies.

Identifiants

pubmed: 37284692
doi: 10.47176/mjiri.37.40
pmc: PMC10240548
doi:

Types de publication

Journal Article

Langues

eng

Pagination

40

Informations de copyright

© 2023 Iran University of Medical Sciences.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

Epilepsia. 2022 Mar;63(3):513-524
pubmed: 34981509
J Neurosci. 1997 Oct 15;17(20):7662-72
pubmed: 9315888
Epilepsia Open. 2018 Nov 02;3(4):460-473
pubmed: 30525115
Science. 1989 Aug 11;245(4918):648-51
pubmed: 2569762
Can J Physiol Pharmacol. 1980 May;58(5):579-82
pubmed: 7417888
Brain Res. 1998 Sep 28;806(2):186-95
pubmed: 9739139
J Physiol. 2010 May 1;588(Pt 9):1527-40
pubmed: 20211979
Epilepsy Res. 2021 Dec;178:106821
pubmed: 34839145
Neuropharmacology. 2013 Jun;69:37-44
pubmed: 22776544
J Neurophysiol. 2015 Jul;114(1):21-8
pubmed: 25925325
J Physiol. 1983 Feb;335:353-74
pubmed: 6875883
J Neurosci Methods. 1981 Aug;4(2):153-6
pubmed: 7278366
Lancet Neurol. 2021 Dec;20(12):1038-1047
pubmed: 34710360
Exp Brain Res. 1996 Apr;109(1):71-82
pubmed: 8740210
J Neurosci. 1997 Dec 1;17(23):9308-14
pubmed: 9364076
Pharmacol Ther. 2019 Sep;201:77-93
pubmed: 31128154
J Neurophysiol. 2005 Oct;94(4):2987-92
pubmed: 16000527
J Neurophysiol. 1999 Nov;82(5):2262-70
pubmed: 10561404
Brain Res. 2021 Aug 15;1765:147492
pubmed: 33887250
Neuroscience. 2018 Jan 15;369:87-96
pubmed: 29138107
J Physiol. 1984 Sep;354:185-201
pubmed: 6481633
Brain. 2018 Sep 1;141(9):2631-2643
pubmed: 29985998
Nature. 1977 Jun 23;267(5613):720-1
pubmed: 195224
Brain Res. 1992 Sep 11;590(1-2):128-35
pubmed: 1422827
Hippocampus. 2012 Jan;22(1):98-105
pubmed: 20882549
Int J Neurosci. 2023 May;133(5):496-504
pubmed: 33998961
Neurobiol Dis. 2005 Jun-Jul;19(1-2):119-28
pubmed: 15837567
Nature. 1997 Feb 13;385(6617):630-4
pubmed: 9024660
J Neurophysiol. 2000 Jul;84(1):274-80
pubmed: 10899202
J Neurophysiol. 1991 Aug;66(2):635-50
pubmed: 1663538
J Neurophysiol. 1987 Mar;57(3):869-88
pubmed: 3031235
Brain Res. 2019 Mar 1;1706:184-195
pubmed: 30419223
Ann Neurol. 1977 May;1(5):463-9
pubmed: 617260
J Neurosci. 1992 Jan;12(1):104-15
pubmed: 1309571
J Neurophysiol. 1995 Feb;73(2):876-9
pubmed: 7760143
Brain Res. 1986 Dec 3;399(1):194-9
pubmed: 3801922
J Neurophysiol. 2000 Oct;84(4):1894-906
pubmed: 11024082
Biophys J. 1978 May;22(2):283-94
pubmed: 656545
J Neurophysiol. 2007 Mar;97(3):1887-902
pubmed: 17151229
Brain Res Bull. 2020 Dec;165:1-13
pubmed: 32961285
CNS Neurol Disord Drug Targets. 2022 Nov 28;:
pubmed: 36443981
Biophys J. 2003 Jan;84(1):687-95
pubmed: 12524321
J Neurophysiol. 1987 Aug;58(2):404-16
pubmed: 3655875
Curr Drug Targets. 2021;22(3):356-367
pubmed: 33023444
Prog Neurobiol. 2002 Oct;68(3):167-207
pubmed: 12450487
Epilepsia. 2021 Jan;62(1):190-197
pubmed: 33258105
Neuroscience. 2008 Jan 2;151(1):303-12
pubmed: 18082973
Pharmacol Ther. 2013 May;138(2):211-28
pubmed: 23353099
J Neurophysiol. 1959 Jul;22(4):436-50
pubmed: 13673295
J Physiol. 2001 Feb 15;531(Pt 1):181-91
pubmed: 11179402
Brain Res. 1986 Nov 19;398(1):215-9
pubmed: 3801897
Epilepsy Curr. 2011 Sep;11(5):153-4
pubmed: 22020786
J Neurosci. 1998 Sep 15;18(18):7543-51
pubmed: 9736672
J Neurophysiol. 1988 Jan;59(1):259-76
pubmed: 3343603
J Gen Physiol. 1971 Dec;58(6):667-87
pubmed: 5120393
Brain Res. 2004 Feb 13;998(1):56-64
pubmed: 14725968
Science. 1982 Nov 19;218(4574):810-2
pubmed: 7134978
Cureus. 2021 Sep 22;13(9):e18199
pubmed: 34584817
J Neurophysiol. 1996 Dec;76(6):4202-5
pubmed: 8985916
Epilepsia. 2008 Aug;49(8):1358-66
pubmed: 18410365
J Neurophysiol. 1985 Nov;54(5):1363-74
pubmed: 2416891
J Neurosci. 1996 Jun 15;16(12):3912-24
pubmed: 8656285
J Neurophysiol. 1986 Aug;56(2):424-38
pubmed: 3760929
Neuroscience. 2019 May 15;406:176-185
pubmed: 30872164
Neuropeptides. 2015 Feb;49:15-23
pubmed: 25481799
J Physiol. 2013 Nov 15;591(22):5765-90
pubmed: 23981713
Epilepsia. 2002 Dec;43(12):1469-79
pubmed: 12460247
J Physiol. 2003 Mar 1;547(Pt 2):427-34
pubmed: 12562909
J Comput Neurosci. 1994 Jun;1(1-2):39-60
pubmed: 8792224
Brain Res. 1984 Dec 10;323(2):227-37
pubmed: 6098340
Neuroscience. 1996 May;72(2):399-408
pubmed: 8737410
Prog Neurobiol. 2011 Oct;95(2):104-32
pubmed: 21802488
Exp Neurol. 2013 Feb;240:28-43
pubmed: 23123405
Neurology. 2015 Mar 10;84(10):1017-25
pubmed: 25663221
J Neurophysiol. 2003 Oct;90(4):2253-60
pubmed: 14534265
Front Neurol. 2022 Apr 28;13:908163
pubmed: 35572920
J Physiol. 1957 Dec 3;139(2):178-90
pubmed: 13492207
Cell J. 2018 Oct;20(3):355-360
pubmed: 29845789
Neuroscience. 2003;120(1):75-84
pubmed: 12849742
J Neurophysiol. 2016 Jun 1;115(6):3229-37
pubmed: 27075542

Auteurs

Marzieh Khodadadi (M)

Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.

Meysam Zare (M)

Department of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Zahra Ghasemi (Z)

Lunenfeld-Tanenbaum Research Institute, Toronto, Canada.

Fariba Karimzadeh (F)

Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.

Fereshteh Golab (F)

Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.

Naser Amini (N)

Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.

Soraya Mehrabi (S)

Department of Physiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Mohammad Taghi Joghataei (MT)

Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
Department of Anatomy, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Nooshin Ahmadirad (N)

Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.

Classifications MeSH